Keyphrases
Nanoparticles
100%
Vascular Endothelial Growth Factor
100%
Doxorubicin
100%
RNA Interference
100%
Synergistic Antitumor Effect
100%
Combination Treatment
100%
Drug Resistance
100%
Toxicity Resistance
60%
Low-dose Chemotherapy
60%
Tumor Growth
40%
Small Interfering RNA (siRNA)
40%
Cancer Cells
40%
Tumor Tissue
40%
Cytotoxic Drugs
40%
All Cancer
40%
Apoptosis
20%
Glycol chitosan
20%
Tumor Regression
20%
Antitumor Effect
20%
Antitumor Activity
20%
Thiolate
20%
Vascular Endothelial Growth Factor Expression
20%
Gene Knockout
20%
Sequence Specificity
20%
Antiangiogenic Activity
20%
Treatment Strategy
20%
Maximum Tolerated Dose
20%
Systemic Toxicity
20%
Polymerized siRNA
20%
Antiangiogenic
20%
Single Treatment
20%
Continuous Treatment
20%
Anti-angiogenesis
20%
Toxic Side Effects
20%
Conventional Cancer Treatment
20%
Synergistic Approach
20%
Chemotherapeutic Approaches
20%
Off Therapy
20%
Anti-angiogenic Strategies
20%
Maximum Tolerated Dose Chemotherapy
20%
Tumor Endothelial Cells
20%
Metronomic Chemotherapy
20%
Systemic Medications
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Vasculotropin
100%
Doxorubicin
100%
Chemotherapy
83%
Drug Resistance
83%
Neoplasm
50%
Malignant Neoplasm
50%
Small Interfering RNA
50%
Antiangiogenic
50%
Tumor Growth
33%
Maximum Tolerated Dose
33%
Cytotoxic Agent
33%
Chitosan
16%
Tumor Regression
16%
Antitumor Activity
16%
Side Effect
16%